Cencora Strengthens Commitment to Oncology Through Acquisition
Cencora, Inc. has made a significant move by finalizing an agreement to acquire TPG's equity interest in OneOncology. This acquisition marks a pivotal milestone for OneOncology, enhancing its position as a physician-led national platform. This development aligns with Cencora's vision to empower independent medical practices, particularly in oncology.
Strategic Importance of the Acquisition
The agreement is a substantial leap forward for OneOncology and its network of practice partners. With a strong backing from Cencora, this acquisition aims to foster investment and growth that will ultimately benefit patients receiving care through these practices. The coalition between Cencora and OneOncology is anticipated to create a more robust infrastructure for independent physicians, ensuring higher access to quality care.
Voices from Leadership
Jeff Patton, M.D., the CEO of OneOncology, expressed enthusiasm about advancing their partnership with Cencora, noting their shared dedication to independent providers. He emphasized that this collaboration would enhance their capabilities in delivering high-quality cancer care amidst the increasing complexities of treatment options available today. The goal remains clear: to provide accessible and innovative solutions to patients.
Advance in Specialty Care and Patient Access
Cencora's investment is a testament to their commitment to specialty care and support for independent providers. This partnership aims to accelerate OneOncology's ability to add value through growth-oriented strategies, innovative clinical solutions, and enhanced operational support. Bob Mauch, President & CEO of Cencora, highlighted the excitement surrounding this acquisition, emphasizing a pharmaceutical-centric strategy that is tailored for growth.
Enhancing Care Through Innovation
The collaborative effort aims not just to scale operations but also to maintain the independence of medical practices. This strategic move is designed to help practices focus on patient care while benefiting from shared resources and advanced technology. This ensures every physician can dedicate their energy to what they do best: providing remarkable care.
Increased Value for Patients and Providers
As the landscape of cancer care continues to evolve, the partnership between Cencora and OneOncology stands as a promising enhancement for many practices. The substantial growth witnessed by OneOncology since its inception thrives on its unique physician-led model, which continues to attract top-tier practices and enhance access to care across communities.
Commitment from TPG and Future Outlook
TPG has played a crucial role in assisting OneOncology's growth since its inception, supporting its mission of improving patient experiences and outcomes. Kendall Garrison, a partner at TPG, commented on their accomplishment in expanding OneOncology's reach and integrating best-in-class practices. With Cencora now at the helm, the focus will be on sustaining and amplifying these efforts.
About OneOncology
OneOncology is dedicated to enhancing the experience of everyone affected by cancer. Founded by community physicians committed to supporting independent practices, the platform emphasizes patient access to care at a competitive cost relative to hospital settings. It empowers its 36 partner practices consisting of over 2,300 providers, ensuring their mission aligns with enhancing healthcare within local communities.
About Cencora
Cencora stands as a key player in global pharmaceutical solutions, focused on bettering lives worldwide through efficient delivery of therapies. With over 51,000 employees, their commitment to positive health outcomes is unwavering, making them one of the top firms in the pharmaceutical sector.
About TPG
Established in 1992, TPG is a prominent alternative asset management firm with broad investment capabilities. Committed to fostering collaboration and innovation, TPG strives to create substantial value across various investment strategies including private equity, impact, and credit.
Frequently Asked Questions
What does Cencora's acquisition of OneOncology entail?
The acquisition involves Cencora taking over TPG's equity interest in OneOncology, enhancing their collaboration to improve oncology care.
How will this acquisition impact patient care?
Patients can expect increased access to high-quality care and innovative treatment solutions as a result of enhanced resources and shared expertise.
Who benefits from the partnership between Cencora and OneOncology?
Independent medical practices and their patients stand to gain the most from this partnership as it aims to strengthen operational capabilities and patient access.
What is the mission of OneOncology?
OneOncology is committed to improving the lives of cancer patients by empowering independent practices while ensuring accessible care within communities.
What does Cencora do?
Cencora specializes in pharmaceutical solutions and aims to optimize market access for various therapies while ensuring reliable healthcare delivery.
